Dr. Marianna Foldvari picture.Dr. Marianna Foldvari is the Canada Research Chair in Bionanotechnology and Nanomedicine and a Professor of Pharmaceutical Sciences at the University of Waterloo’s School of Pharmacy. Dr. Foldvari’s expertise is in pharmaceutics, dosage form and drug delivery system design (dermal, transdermal, transmucosal, ocular, intranasal, injectables and needle-free) nanotechnology, non-viral delivery methods and vaccine development. She has over 20 years of experience as an academic researcher and in research and development in the pharmaceutical industry through technology transfer activities. Her research program is focusing on non-invasive drug delivery, gene therapy and pharmaceutical development of nano-enabled products.

Dr. Foldvari's research is supported by grants from Canadian Institutes of Health Research (CIHR), Canada Foundation for Innovation (CFI) and Natural Sciences and Engineering Research Council of Canada (NSERC). Dr Foldvari is a member of the American Association of Pharmaceutical Scientists, American Society for Gene and Cell Therapy and the Controlled Release Society. She currently serves as Associate Editor for Precision Nanomedicine and Editorial Board Member for the Journal of Controlled Release.

Dr. Foldvari served as a grant reviewer on CIHR, NSERC, CFI and NIH panels and the Bill and Melinda Gates Foundation Global Health Initiatives review board. Dr. Foldvari is one of the Founding Directors of the American Society for Nanomedicine (ASNM) and the International Society of Nanomedicine (ISNM). She served as Board Member for Genome Prairie and was a Member of the Advisory Committee to the Prime Minister on Science and Technology and a Founder of the Canadian Society of Pharmaceutical Sciences (CSPS). She is an AAPS Fellow and received the AFPC Pfizer Research Career Award, the Honorary Award for Outstanding Lifetime Achievements in Nanoscience and Nanotechnology in Ontario, the YWCA Women of Distinction Award and the Sabex Award of Innovation. She is a frequently invited speaker at national and international conferences on gene and protein delivery systems and nanomedicine development and applications. Dr. Foldvari has authored more than 150 papers and 100 conference presentations and is the inventor on 25 patents.

Education

- PhD, Pharmaceutical Sciences
College of Pharmacy, Dalhousie University, Halifax, Nova Scotia

- D Pharm Sci, Doctorate in Pharmaceutical Sciences
Summa cum laude, Faculty of Pharmacy
Semmelweis Medical University, Budapest, Hungary

- BSc, Faculty of Pharmacy
Semmelweis Medical University, Budapest, Hungary

Positions and Honors

  • 2007–2014  Canada Research Chair in Bionanotechnology and Nanomedicine (CIHR, Tier 1), University of Waterloo
  • 2006–to date Professor (tenured) of Pharmaceutical Sciences, School of Pharmacy and the Waterloo Institute of Nanotechnology, University of Waterloo
  • 2007-to date  Waterloo Institute of Nanotechnology
  • 2007-to date  Center for Bioengineering and Biotechnology
  • 2007–2010    Associate Director, Research and Graduate Studies, School of Pharmacy, University of Waterloo
  • 2006–to date Adjunct Professor, College of Pharmacy and Nutrition, University of Saskatchewan
  • 2006 Visiting Professor, Department of Chemical Engineering, Robert Langer’s Laboratory, MIT
  • 2004–2006    Associate Dean Research and Graduate Affairs, University of Saskatchewan
  • 1998–2000    Head, Division of Pharmaceutical Sciences, University of Saskatchewan
  • 1999–2002    Vice President R&D, Helix BioPharma Inc.
  • 1996–1999    Helix Chair in Industrial Pharmacy, University of Saskatchewan
  • 1991–2002    President and Director R&D, PharmaDerm Laboratories Ltd.
  • 1999–2006    Professor (tenured), College of Pharmacy and Nutrition, University of Saskatchewan
  • 1991–1998    Associate Professor, College of Pharmacy and Nutrition, University of Saskatchewan
  • 1988–1991    Assistant Professor, College of Pharmacy and Nutrition, University of Saskatchewan

Distinctions and Awards

  • Waterloo Institute of Nanotechnology (WIN) Research Leaders Award, 2018
  • Honorary Award for Outstanding Lifetime Achievements in Nanoscience and Nanotechnology in Ontario, 2017
  • AAPS Fellow, 2017
  • The AFPC Pfizer Research Career Award, 2017
  • YWCA Women of Distinction Award Recipient (entrepreneur/innovator category), 1997
  • Helix Chair in Industrial Pharmacy, University of Saskatchewan, 1996–1999
  • Listing in A. Wood, Canadian Women Invent!, 2001
  • Award of Innovation, University of Saskatchewan and Innovation Place, 2005
  • Saskatchewan 25 Science Achievements, Government of Saskatchewan, Saskatchewan Centennial
  • Sabex Award of Innovation
  • YWCA Women of Distinction Award Recipient (Entrepreneur/Innovator Category)
  • Scanning Microscopy International Presidential Scholarship for Conference Presentation Robert A. Chesebrough Gold Medal for Original Research on Vaseline® Petroleum Jelly (Third Place)
  • Izaak Walton Killam Memorial Scholarship

Professional activities

  • Associate Editor, Nanomedicine: Nanotechnology, Biology, and Medicine
  • Editorial Board Member, Journal of Controlled Release

Memberships

Affiliations

WIN logo.

Waterloo Institute for Nanotechnology, University of Waterloo

 

School of Pharmacy logo.

School of Pharmacy, University of Waterloo

 

Waterloo Faculty of Engineering logo.

Chemical Engineering, University of Waterloo

 

GWC2 logo.

Guelph-Waterloo Centre for Graduate Work in Chemistry and Biochemistry (GWC2)

 

University of Saskatchewan logo.

College of Pharmacy and Nutrition,      University of Saskatchewan

 

CRC logo.

Canada Research Chairs

 

Research Entrepreneurship

Dr. Foldvari founded two spin-off companies that have commercialised drug delivery technologies she and her research group have developed.

PharmaDerm Laboratories Ltd.

Group members of PharmaDerm.